Ann: EuGeni Test Strip Manufacturing Strategy, page-63

I tend to think the price per test is too high. Examples quoted are retail packs, and if a two pack in Walmart is $15-19 then what would effectively be bulk and volume sales in 25-100 packs would be lower.

the other challenge with P/E multiples will be that of using covid testing as the basis - will margins on other tests be as high? Doubtful.

the margin difference between in house and external manufacturing feels about right, but I expect there are still distributors involved and I don’t know how the profit pool is split. Without seeing actual revenue it’s all a bit hypothetical.

however, the 50% discount you apply i would think covers that, so should there be sales for the qty they can supply I’d be looking at that 70-80c valuation in 2022, and more should battery tech progress to commercialisation.